Biomedicine

Abstract

The complex terrain of gender differences in cardiovascular disease (CVD) diagnosis and treatment is explored in this short review article. Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality worldwide, accounting for an estimated 17.9 million deaths each year, representing 32% of all global deaths, with 85% attributed to heart attack and stroke. Men and women are both affected by CVD. However, growing data indicates that there are gender-based variations in the diagnosis, treatment, and prognosis of CVD. This essay illustrates the several factors that contribute to these differences through a succinct assessment of recent literature and empirical evidence. The examination starts by explaining gender differences in symptom presentation, risk factor awareness, and diagnostic precision that may unintentionally delay early diagnosis. In order to shed light on potential biases in care delivery, we also closely examine the variations in treatment approaches, such as medication and interventional treatments. In order to alleviate the uneven CVD burden, it is essential to comprehend these gender differences. This paper emphasizes how crucial it is to use gender-sensitive clinical practices, policy development, and healthcare education to address these inequities and guarantee fair cardiovascular health outcomes for everyone, regardless of gender.